Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 128Colonic Neoplasms 54Rectal Neoplasms 49Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 20Pancreatic Neoplasms 10Cholangiocarcinoma 9Neoplasms 8Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Unresectable Metastatic Colorectal Cancer 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Breast Neoplasms 2Adenocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1

Interventions

Oxaliplatin 1Levoleucovorin 1Leucovorin 1Folfox protocol 1Fluorouracil 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumour × Folfox protocol × Gastrointestinal × Clear all
NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

SCRI Development Innovations, LLC

Phase 1/2 Completed
49 enrolled 12 charts
GastrointestinalOther solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡